Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
Holding MNPR?
Track your performance easily

Monopar Therapeutics Inc (MNPR) Financial Statements

423 Followers

Monopar Therapeutics Inc Financial Overview

Monopar Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-2.303; its P/E ratio is -6.84; Monopar Therapeutics Inc is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.79M$ 1.72M$ -2.07M$ -2.33M$ -2.49M
EBITDA$ -1.79M$ 1.72M$ -2.07M$ -2.33M$ -2.49M
Net Income Common Stockholders$ -1.72M$ -1.64M$ -1.95M$ -2.20M$ -2.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.12M$ 7.81M$ 5.52M$ 7.21M$ 5.73M
Total Assets$ 7.18M$ 8.91M$ 8.59M$ 10.34M$ 11.83M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.12M$ -7.81M$ -5.52M$ -7.21M$ -5.73M
Total Liabilities$ 1.09M$ 1.44M$ 1.98M$ 2.50M$ 2.89M
Stockholders Equity$ 6.09M$ 7.48M$ 6.61M$ 7.84M$ 8.94M
Cash Flow-
Free Cash Flow$ -1.68M$ -1.66M$ -1.94M$ -2.10M$ -2.27M
Operating Cash Flow$ -1.68M$ -1.66M$ -1.94M$ -2.10M$ -2.27M
Investing Cash Flow$ -2.42K$ -983.31K$ -13.05K$ 2.95M$ -983.44K
Financing Cash Flow$ -9.92K$ 3.18M$ 246.70K$ 641.18K$ 804.80K
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Monopar Therapeutics Inc Debt to Assets

Monopar Therapeutics Inc Cash Flow

Monopar Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis